Executive Interview – Rex Bionics

Executive Interview – Rex Bionics

Rex Bionics develops and produces exoskeletons to help assist in the rehabilitation and improve the mobility of patients with spinal cord injury and other lower-limb mobility problems. In this interview CEO Crispin Simon explains the product, the markets Rex is targeting and sets out the company’s investment case. He points to the start of clinical trials and entry to new markets as inflection points which may be reached in 2015.


You may also be interested in these:

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free